Warfarin use is associated with progressive coronary arterial calcification: insights from serial intravascular ultrasound
J Andrews, PJ Psaltis, O Bayturan, M Shao… - JACC: Cardiovascular …, 2018 - jacc.org
Objectives: This study compared serial changes in coronary percent atheroma volume (PAV)
and calcium index (CaI) in patients with coronary artery disease who were treated with and …
and calcium index (CaI) in patients with coronary artery disease who were treated with and …
Coronary CT angiography: variability of CT scanners and readers in measurement of plaque volume
Purpose To determine reader and computed tomography (CT) scan variability for
measurement of coronary plaque volume. Materials and Methods This HIPAA-compliant …
measurement of coronary plaque volume. Materials and Methods This HIPAA-compliant …
Factors underlying regression of coronary atheroma with potent statin therapy
Aims Statins can inhibit the progression of coronary atherosclerosis. We aimed to
characterize clinical factors that associate with differing measures of coronary atheroma …
characterize clinical factors that associate with differing measures of coronary atheroma …
Artificial intelligence in intracoronary imaging
Abstract Purpose of Review This paper investigates present uses and future potential of
artificial intelligence (AI) applied to intracoronary imaging technologies. Recent Findings …
artificial intelligence (AI) applied to intracoronary imaging technologies. Recent Findings …
[HTML][HTML] Effect of serial infusions of reconstituted high-density lipoprotein (CER-001) on coronary atherosclerosis: rationale and design of the CARAT study
J Andrews, A Janssan, T Nguyen… - Cardiovascular …, 2017 - ncbi.nlm.nih.gov
Background High-density lipoprotein (HDL) is believed to have atheroprotective properties,
but an effective HDL-based therapy remains elusive. Early studies have suggested that …
but an effective HDL-based therapy remains elusive. Early studies have suggested that …
Impact of PCSK9 inhibition on coronary atheroma progression: Rationale and design of Global Assessment of Plaque Regression with a PCSK9 Antibody as …
Background Statin-mediated low-density lipoprotein cholesterol (LDL-C) lowering fails to
prevent more than half of cardiovascular events in clinical trials. Serial plaque imaging …
prevent more than half of cardiovascular events in clinical trials. Serial plaque imaging …
Imaging of coronary atherosclerosis—evolution towards new treatment strategies
Coronary atherosclerosis and the precipitation of acute myocardial infarction are highly
complex processes, which makes accurate risk prediction challenging. Rapid developments …
complex processes, which makes accurate risk prediction challenging. Rapid developments …
Prognostic value of intravascular ultrasound in patients with coronary artery disease
AS Schuurman, MM Vroegindewey, I Kardys… - Journal of the American …, 2018 - jacc.org
Background: It has been shown that intravascular ultrasound (IVUS) and radiofrequency (RF-
) IVUS can detect high-risk coronary plaque characteristics. Objectives: The authors studied …
) IVUS can detect high-risk coronary plaque characteristics. Objectives: The authors studied …
Дислипидемии, атеросклероз и ишемическая болезнь сердца: современные аспекты патогенеза, диагностики и лечения
ИВ Сергиенко, АА Аншелес, ВВ Кухарчук - 2018 - elibrary.ru
В третье издание монографии, посвященной атеросклерозу, вошла предыдущая книга
авторов «Атеросклероз и дислипидемии», выпущенная в 2017 г., а также новые главы …
авторов «Атеросклероз и дислипидемии», выпущенная в 2017 г., а также новые главы …
Atheroma progression in hyporesponders to statin therapy
Y Kataoka, J St. John, K Wolski, K Uno… - … , and vascular biology, 2015 - Am Heart Assoc
Objective—Lowering low-density lipoprotein cholesterol (LDL-C) with statins has been
demonstrated to slow plaque progression. This antiatherosclerotic effect in patients with …
demonstrated to slow plaque progression. This antiatherosclerotic effect in patients with …